IBT Bioservices
MISSION
IBT Bioservices is the contract research division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a strong client-oriented research and development service focused on our area of expertise, infectious diseases. The team at IBT Bioservices has extensive experience in antiviral and antibacterial screening and model development. Tokyo Future Style offers reagents manufactured by IBT Bioservices.
Product list
Alphaviruses
Alphaviruses are arthropod-borne viruses that cause disease in humans and a wide range of domestic and agricultural animals. Interest in development of alphavirus therapeutics and vaccines has risen in recent years due to epidemics of Chikungunya virus (CHIKV) causing severe illness in Africa and Asia and concerns about possible use of Venezuelan equine encephalitis virus (VEE) as an agent of bioterrorism. IBT’s alphavirus reagent line covers Chikungunya and Venezuelan Equine Encephalitis Virus. Reagents include antisera and purified polyclonal antibodies. Specific targets include CHIKV, CHIKV E2 protein, and VEE.
| Name | target | Code | Volume | Data sheet |
| Rabbit anti-Chikungunya (CHIKV) pAb | Chikungunya Virus | 04-0008 | 500 ug |  |
| Rabbit anti-CHIKV E2 pAb | Chikungunya Virus | 0306-001 | 100 ug | |
| Rabbit anti-EEEV E2 GP pAb | Eastern Equine Encephalitis Virus | 0318-001 | 100 ug | |
| Recombinant EEEV E2 GP (E3E2) | Eastern Equine Encephalitis Virus | 0560-001 | 100 ug | |
| Rabbit anti-Venezuelan Equine Encephalitis (VEE) pAb | Venezuelan Equine Encephalitis Virus | 04-0002 | 500 ug | |
| Rabbit anti-WEEV E2 GP pAb | Western Equine Encephalitis Virus | 0319-001 | 100 ug | |
| Recombinant WEEV E2 GP (E3E2) | Western Equine Encephalitis Virus | 0561-001 | 100 ug | |
| Recombinant WEEV E2 GP (E3E2) – (mammalian) | Western Equine Encephalitis Virus | 0562-001 | 100 ug | |
Filoviruses
Filoviruses such as Ebola, Sudan, Marburg and others are deadly pathogens which cause hemorrhagic fevers. The 2014 Ebola outbreak has caused more than 10,000 deaths. IBT offers the most comprehensive collection of commercially available reagents to support filovirus vaccine, therapeutic, and diagnostic research. IBT’s filovirus reagent line covers many filovirus species such as Ebola, Sudan, Marburg, Bundibugyo, and Reston and multiple virus components including key virus proteins and protein domains. Product types include recombinant proteins; monoclonal and polyclonal antibodies; antisera; etc. Specific targets covered include GP; L; NP; VP40; transmembrane and mucin-like domains; and others.
| Name | Target | Code | Volume | Data sheet |
| Rabbit anti-BDBV GP pAb | Bundibugyo Virus | 0304-001 | 100 ug | |
| Recombinant BDBV GPDTM | Bundibugyo Virus | 0505-015 | 100 ug | |
| Recombinant EBOV VP24 | Ebola Virus | 0501-030 | 100 ug | |
| Recombinant EBOV GPDTM (mammalian) | Ebola Virus | 0501-001 | 100 ug | |
| Chimeric anti-EBOV GP mAb (c6D8) | Ebola Virus | 0201-021 | 100 ug | |
| Chimeric anti-EBOV GP mAb (h13C6 FR1) | Ebola Virus | 0201-023 | 100 ug | |
| Chimeric anti-EBOV GP mAb (h13F6) | Ebola Virus | 0201-022 | 100 ug | |
| Ebola Virus Delta Peptide | Ebola Virus | 0509-001 | 100 ug | |
| Ebola virus-like particles (EBOV VLP) | Ebola Virus | 0550-001 | 1 mg | |
| EBOV Soluble GP (sGP) ELISA Kit | Ebola Virus | 0100-001 | 1 ea | |
| Human anti-EBOV GP mAb (KZ52) | Ebola Virus | 0260-001 | 100 ug | |
| Mouse anti-(EBOV GP) mAb (4F3) | Ebola Virus | 0201-020 | 100 ug | |
| Mouse anti-EBOV VP40 mAb (3G5) | Ebola Virus | 0201-016 | 100 ug | |
| Mouse anti-EBOV VP40 mAb (5B12) | Ebola Virus | 0201-017 | 100 ug | |
| Mouse anti-EBOV VP40 mAb (AE11) | Ebola Virus | 0201-018 | 100 ug | |
| Rabbit anti-EBOV Delta Peptide | Ebola Virus | 0366-001 | 100 ug | |
| Rabbit anti-EBOV GP pAb | Ebola Virus | 0301-015 | 100 ug | |
| Rabbit anti-EBOV GP pAb Biotinylated | Ebola Virus | 0301-015-bio | 100 ug | |
| Rabbit anti-EBOV L-Polymerase pAb | Ebola Virus | 0301-045 | 100 ug | |
| Rabbit anti-EBOV NP pAb | Ebola Virus | 0301-012 | 100 ug | |
| Rabbit anti-EBOV Soluble GP (sGP) pAb | Ebola Virus | 0365-001 | 100 ug | |
| Rabbit anti-EBOV VLP pAb | Ebola Virus | 0315-001 | 500 ug | |
| Rabbit anti-EBOV VP35 pAb | Ebola Virus | 0301-040 | 100 ug | |
| Rabbit anti-EBOV VP40 pAb | Ebola Virus | 0301-010 | 100 ug | |
| Recombinant EBOV GPDTM | Ebola Virus | 0501-015 | 100 ug | |
| Recombinant EBOV GPDTM | Ebola Virus | 0501-016 | 500 ug | |
| Recombinant EBOV Soluble GP (sGP) | Ebola Virus | 0565-001 | 100 ug | |
| Recombinant EBOV VP40 | Ebola Virus | 0564-001 | 100 ug | |
| Pan-Filovirus Mouse anti-GP mAb | Ebola, Sudan, Marburg virus | 0200-001 | 100 ug | |
| Recombinant MMARV GPDTM w/His-tag | Marburg Virus | 0000-000 | 100 ug | |
| Musoke-Marburg virus-like particles (MMARV VLP) | Marburg Virus | 0566-001 | 1 mg | |
| Mouse anti-MARV GP mAb (5C1) | Marburg Virus | 0203-023 | 100 ug | |
| Mouse anti-MARV VP40 mAb (1D1) | Marburg Virus | 0203-012 | 100 ug | |
| Mouse anti-MMARV VP40 mAb (6B1) | Marburg Virus | 0203-016 | 100 ug | |
| Rabbit anti-MARV GP pAb | Marburg Virus | 0303-007 | 100 ug | |
| Rabbit anti-MARV GP pAb Biotinylated | Marburg Virus | 0303-007-bio | 100 ug | |
| Rabbit anti-MARV NP pAb | Marburg Virus | 0303-012 | 100 ug | |
| Rabbit anti-MARV VLP pAb | Marburg Virus | 04-0005 | 500 ug | |
| Rabbit anti-MARV VP40 pAb | Marburg Virus | 0303-001 | 100 ug | |
| Recombinant AMARV GPDTM | Marburg Virus | 0506-015 | 100 ug | |
| Recombinant AMARV GPDTM | Marburg Virus | 0506-016 | 500 ug | |
| Recombinant MARV VP40 | Marburg Virus | 0568-001 | 100 ug | |
| Rabbit anti-RESTV GP pAb | Reston Virus | 0305-001 | 100 ug | |
| Recombinant RESTV GPDTM | Reston Virus | 0504-015 | 100 ug | |
| Mouse anti-SUDV GP mAb (16F6) | Sudan Virus | 0280-001 | 100 ug | |
| Mouse anti-SUDV GP mAb (2H5) | Sudan Virus | 0202-029 | 100 ug | |
| Mouse anti-SUDV VP40 mAb (1G10) | Sudan Virus | 0202-018 | 100 ug | |
| Rabbit anti-SUDV GP pAb | Sudan Virus | 0302-020 | 500 ug | |
| Rabbit anti-SUDV NP pAb | Sudan Virus | 0302-012 | 100 ug | |
| Rabbit anti-SUDV VP40 pAb | Sudan Virus | 0302-001 | 100 ug | |
| Recombinant SUDV GPDTM | Sudan Virus | 0502-015 | 100 ug | |
| Recombinant SUDV VP40 | Sudan Virus | 0569-001 | 100 ug | |
| Sudan virus-like particles (SUDV VLP) | Sudan Virus | 0567-001 | 1 mg | |
Influenza
Influenza virus is a major pathogen which causes epidemics and pandemics worldwide. IBT’s influenza reagent line covers hemagglutinins for a range of influenza subtypes. The reagents are expressed as full length glycoprotein and demonstrate hemagglutination activity similar to the wild type virus. Specific targets include influenza hemagglutinins H1, H5, H7, H9, and H10.
| Name | Target | Code | Volume | Data sheet |
| Recombinant Influenza hemagglutinin H1 Puerto Rico | Influenza Hemagglutinin H1 | 1504-001 | 50 ug | |
| Recombinant Influenza hemagglutinin H10 Jiangxi-Donghu | Influenza Hemagglutinin H10 | 1505-001 | 50 ug | |
| Recombinant Influenza Hemagglutinin H5 Vietnam | Influenza Hemagglutinin H5 | 1501-001 | 50 ug | |
| Recombinant Influenza Hemagglutinin H7 Anhui | Influenza Hemagglutinin H7 | 1502-001 | 50 ug | |
| Recombinant Influenza hemagglutinin H9 Hong Kong | Influenza Hemagglutinin H9 | 1503-001 | 50 ug | |
Other Viruses
IBT’s reagent line covers a range of viruses. Product types include antisera, and purified polyclonal antibodies against these viruses.
Specific targets covered include Crimean-Congo Hemorrhagic Fever Virus (CCHFV); Japanese Encephalitis Virus (JEV); Junin and Lassa Viruses; Rift Valley Fever Virus (RVFV); Vaccinia; etc.
| Name | target | Code | Volume | Data sheet |
| Rabbit anti-CCHFV N protein pAb | Crimean-Congo Hemorrhagic Fever Virus | 04-0011 | 100 ug | |
| Rabbit anti-Junin pAb | Junin Virus | 04-0006 | 500 ug | |
| Rabbit anti-LASV GP pAb | Lassa Virus | 0307-001 | 100 ug | |
| Rabbit anti-LASV Z pAb | Lassa Virus | 0307-002 | 100 ug | |
| Recombinant Lassa Virus Z Protein | Lassa Virus | 0508-001 | 100 ug | |
| Rabbit anti-Rift Valley Fever (RVFV) pAb | Rift Valley Fever Virus | 04-0001 | 500 ug | |
| Rabbit anti-Zika NS1 pAb | Zika Virus | 0308-002 | 100 ug | |
| Rabbit anti-Zika GP pAb | Zika Virus | 0308-001 | 100 ug | |
Clostridium
Clostridium difficile and Clostridium perfringens are Gram-positive bacteria responsible for food poisoning and serious intestinal infections. IBT’s Clostridium reagent line consists of monoclonal antibodies against Clostridium virulence factors. Specific targets covered include C. difficile Toxin A and B; and C. perfringens Epsilon toxin (ETX).
| Name | Target | Code | Volume | Data sheet |
| Human anti-(C. difficile toxin A) mAb | C. difficile toxin A | 0250-001 | 100 ug | |
| Human anti-(C. difficile toxin B) mAb | C. difficile toxin B | 0250-002 | 100 ug | |
| Chimeric anti-(C. perfringens ETX) mAb | C. perfringens ETX | 0240-001 | 100 ug | |
Staphylococcus
Staphylococcus aureus is a bacterium which is a leading cause of hospital and community acquired infections. IBT’s S. aureusreagent line covers a range of virulence factors such as toxins, pore-forming toxins, superantigens, hemolysins, etc. Product types include recombinant, functionally active, purified proteins; monoclonal and polyclonal antibodies; etc. Specific targets covered include alpha hemolysin (alpha-toxin); gamma hemolysin (Hlg); Panton-Valentine Leukocidin (PVL); staphylococcal enterotoxin A (SEA); staphylococcal enterotoxin B (SEB); toxic shock syndrome toxin 1 (TSST-1); bicomponent toxins such as LukS-PV, LukF-PV, HlgB, and HlgC; and others.
| Name | Target | Code | Volume | Data sheet |
| Mouse anti-Hla mAb (6C12) | Hla | 0210-005 | 100 ug | |
| Mouse anti-Hla mAb (8B7) | Hla | 0210-001 | 100 ug | |
| Rabbit anti-Hla pAb | Hla | 04-0010 | 500 ug | |
| Recombinant Hla (tag free) | Hla | 1401-002 | 100 ug | |
| Recombinant Hld | Hld | 1401-003 | 100 ug | |
| Recombinant Hlg A (tag free) | Hlg A | 1403-003 | 100 ug | |
| Rabbit anti-Hlg B pAb | Hlg B | 0314-001 | 500 ug | |
| Recombinant Hlg B (tag-free) | Hlg B | 1404-001 | 100 ug | |
| Rabbit anti-Hlg C pAb | Hlg C | 0314-002 | 500 ug | |
| Recombinant Hlg C (tag-free) | Hlg C | 1405-001 | 100 ug | |
| Lipoteichoic acid (LTA) | LTA | 1600-001 | 5 mg | |
| Mouse anti-LTA mAb | LTA | 0270-001 | 200 ug | |
| Rabbit anti-LukA pAb | LukA | 0316-001 | 100 ug | |
| Rabbit anti-LukB pAb | LukB | 0317-001 | 100 ug | |
| Recombinant LukD (tag free) | LukD | 0530-003 | 100 ug | |
| Recombinant LukE (tag free) | LukE | 0530-004 | 100 ug | |
| Rabbit anti-LukF-PV pAb | LukF-PV | 0312-002 | 500 ug | |
| Recombinant LukF-PV (His tagged) | LukF-PV | 0536-001 | 100 ug | |
| Recombinant LukF-PV (tag free) | LukF-PV | 0540-002 | 100 ug | |
| Mouse anti-LukS-PV mAb (1D9) | LukS-PV | 0221-001 | 100 ug | |
| Rabbit anti-LukS-PV pAb | LukS-PV | 04-0009 | 500 ug | |
| Recombinant LukS-PV (His tagged) | LukS-PV | 0530-001 | 100 ug | |
| Recombinant LukS-PV (tag free) | LukS-PV | 0540-001 | 100 ug | |
| PSM-Alpha 3 | PSM Alpha 3 | 1401-004 | 100 ug | |
| Rabbit anti-(SEA, SEB, TSST-1) pAb | SEA, SEB, TSST-1 | 0311-001 | 500 ug | |
| Mouse anti-SEB mAb (2C1) | SEB | 0220-013 | 100 ug | |
| Mouse anti-SEB mAb (3D10) | SEB | 0220-009 | 100 ug | |
| Recombinant TSST-1 (tag free) | TSST-1 | 1402-001 | 100 ug | |
若您對於頁面產品有任何疑問及需求，請與我們聯繫
Tokyo Future Style Taiwan
info-tw@tokyofuturestyle.com
TEL : +886-2-25785958 FAX : +886-2-25789826
